Kam‐Leung Siu

3.3k citations
25 papers · 2.2k indexed · 1 hit paper · h-index 18

Kam‐Leung Siu

23 papers receiving 2.2k citations

Hit Papers

Severe acute respiratory syndrome Coronavirus ORF3a prote...20192026202120232019100200300

Peers

Kam‐Leung Siu
Comparison fields: 5 of 102
  • Molecular Biology 956
  • Infectious Diseases 932
  • Immunology 736
  • Oncology 283
  • Epidemiology 277
Replace Chong-Shan Shi with:
Chong-Shan Shi United States
Yi Zheng China
Krystal Matthews United States
Jin Wei China
Lucile Espert France
Gulam Hussain Syed India
Jamie L. Fornek United States
Yong Lin China
Nicholas J. Matheson United Kingdom
Yeou‐Guang Tsay Taiwan
Kam‐Leung Siu relative to Chong-Shan Shi United States Chong-Shan Shi's profile →
Citations per field
00.5×1.5×2.4×
Chong-Shan Shi · 1×
Citations per year

Countries citing papers authored by Kam‐Leung Siu

Since Specialization
Citations

This map shows the geographic impact of Kam‐Leung Siu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kam‐Leung Siu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kam‐Leung Siu more than expected).

Fields of papers citing papers by Kam‐Leung Siu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kam‐Leung Siu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kam‐Leung Siu. The network helps show where Kam‐Leung Siu may publish in the future.

Co-authorship network of co-authors of Kam‐Leung Siu

This figure shows the co-authorship network connecting the top 25 collaborators of Kam‐Leung Siu. A scholar is included among the top collaborators of Kam‐Leung Siu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kam‐Leung Siu. Kam‐Leung Siu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 7
4 38
5 56
6 29
7 70
8 104
9 10
10 16
11 36
12 83
13 11
14 149
15 37
16 230
17 10
18 369
19 185
20 64

About Kam‐Leung Siu

Kam‐Leung Siu is a scholar working on Immunology, Infectious Diseases and Molecular Biology, having authored 25 papers that have together received 2.2k indexed citations. Recurring topics across this work include interferon and immune responses (12 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Redox biology and oxidative stress (4 papers). The work is most often cited by research in Infectious Diseases (932 citations), Immunology (736 citations) and Animal Science and Zoology (240 citations). Kam‐Leung Siu has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Dong‐Yan Jin, Kin‐Hang Kok, Kwok‐Yung Yuen, Chi‐Ping Chan, Man Lung Yeung, Sin‐Yee Fung, Kit‐San Yuen, Chi‐Ming Wong, Ching-Ping Chan and Dora Lai‐Wan Kwong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026